摘要
[目的]观察中药善胃I号方对慢性萎缩性胃炎(CAG)胃粘膜异型增生的治疗效果 ,并观察ras癌基因蛋白p21在治疗前后的表达情况。[方法]将内镜和病理确诊为CAG胃粘膜异型增生的患者且符合中医血瘀热毒证型82例 ,随机分为治疗组和对照组。治疗组34例 ,予善胃Ⅰ号方 ;对照组48例 ,予市售猴头菌片 ,两组均用药12周。[结果]1)治疗组患者治疗前后症状缓解总有效率为81 % ;对照组患者治疗前后症状缓解总有效率为44.74 % ,P<0.005 ;2)病理改变 :中药治疗后多数患者病理改善 ,粘膜萎缩消失8例 ,转为轻度12例 ,重度转为中度7例 ,无变化6例 ,加重1例 ;而对照组消失2例 ,转为轻度4例 ,转为中度5例 ,无变化33例 ,加重4例 ,中药组明显优于对照组 ,P<0.005 ;3)中药治疗组治疗前后 p21蛋白表达阳性指数下降较对照组更为明显 ,两者有显着性差异 (P<0.05)。[结论]中药善胃Ⅰ号方对萎缩性胃炎有良好的治疗作用 。
To observe the therapeutic effect of Chinese medicine Shanwei I on metaplasia of intestinal mucosa in chronic atrophic gastritis (CAG). To evaluate the expression of oncogene p21 protein in the treatment of CAG. Eighty-two patients with blood stasis and heat-toxin were divided into treatment group(34, given Shanwei I) and control group(48, given Houtoujun tablets) randomly.The treatment course was 12 weeks. 1) The total effective rate was 81% in treatment group and 44.74% in control group with a marked difference between them,(P<0.005).2) The pathological changes were improved obviously in treatment group. It was superior to control group,(P<0.005).3) The expression of p21 protein was decreased obviously in treatment group and there was an obvious difference before and after treatment (P<0.05).[Conclusion]Shanwei I has a good effect on chronic atrophic gastritis and can reverse intestinal metaplasia.
出处
《天津中医药》
CAS
2003年第1期16-18,共3页
Tianjin Journal of Traditional Chinese Medicine
基金
国家自然科学基金资助项目 (30271570)
